课题基金 / 基金详情

AN EFFICACY AND SAFETY STUDY OF 2'3' DDI IN AIDS PATIENTS WITH ADVANCED ARC

AN EFFICACY AND SAFETY STUDY OF 2'3' DDI IN AIDS PATIENTS WITH ADVANCED ARC
23 DDI 对晚期 ARC 艾滋病患者的疗效和安全性研究
批准号：
3763692
负责人：
Fred T Valentine
金额：
$0.0万
依托单位：
NEW YORK UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3763692
关键词：
2'3' dideoxycytidine 2'3' dideoxyinosine AIDS AIDS therapy dosage drug screening /evaluation human subject human therapy evaluation immunopathology chemotherapy oral administration

项目摘要

项目成果

Fred T Valentine的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This study will evaluate the efficacy and toxicity of three doses of orally administered ddI in the treatment of patients with AIDS and advanced ARC who have demonstrated hematological intolerance to zidovudine. It will also determine if the efficacy of ddi increases with increasing dose. (ACTG 118)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Center for AIDS Research
Administrative
Immunopathogenesis of acute and early HIV infection
CD4 RESPONSES TO ANTIRETROVIRAL THERAPY (ART) ALONE OR ART WITH VACCINATION
海外基金